Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Fermentation impurity
Pt-based DNA cross-linker.
β-lactam cephalosporin; penicillin binding pro...
Folic acid derivative
Endogenous neurotransmitter; GABA agonist.
Dihydropyrazine found in Ligusticum walliichi. ...
Coumarin; VKORC1 inhibitor.
Taxoid that disrupts the microtubular network i...
Flavonoid found in various plant sources; matri...
Sirtuin inhibitor and iron chelator.
Selective CDK2 inhibitor.
ITC, erucin analog.
Diarylether; bacterial ENR binder, fatty acid s...
TRPV1 agonist, histamine H1 antagonist.
Macrolide; vacuolar H+-ATPase inhibitor.
Triterpene; potential tyrosinase inhibitor.
Endogenous peptide hormone inolved in gastric e...
Islet α/β cell proliferation stimulator.
c-Raf activator, tyrosine kinase inhibitor.
Nav1.8 Na+ channel blocker, potential Nav1.5 Na...